Excessive sweating treatments with Botox

The treatment of axillary hyperhidrosis by Botox injections is one of the most effective solutions.

Hyperhidrosis is the medical term that describes excess sweating as compared to normal and necessary to regulate body temperature. It is a common symptom that causes a lot of discomfort to the patient.

Hyperhidrosis may be primary or secondary to various diseases (metabolic, nerve, endocrine, febrile) or may occur as an adverse reaction to various medications. The most common is hyperhidrosis in conditions of stress, emotion, heat.
Sweating itself does not have an unpleasant odor, but it favors the development of bacteria and the formation of acids that are subsequently responsible for the appearance of unpleasant odors.

An effective solution for the treatment of axillary hyperhidrosis is the injection of Botox into the affected area.
In aesthetic medicine, Botox has been used and authorized for many years at international wrinkle treatment.

Botox is a purified protein that acts naturally in the muscles of the face, relaxing the muscles, resulting in wrinkle smoothing, and on the axillary level it will block the activity of the sweat glands, which after setting the effect causes a considerable decrease in the amount of sweat produced .

Botox injected into the axillary area will block the activity of sweat glands, which results in a considerable decrease in the amount of perspiration produced after the effect.
The treatment of axillary hyperhidrosis is simple and fast, it is performed under local anesthesia with cream, can be done in a break, and then you can resume activities.
The Effect of Hyperhidrosis Treatment Axilla is installed in 10-14 days, takes about 4-6 months, depending on the individual reactivity, consists in a considerable decrease in the amount of sweat produced in the treated area.

– pregnancy and lactation
– allergens to one of the components used in the preparation of the substance, eg albumin
– pains that cause a general decrease in muscle strength, such as Gravis Miastenia
during treatment with anticoagulants, antibiotics, calcium channel blockers
during treatment with corticosteroid anti-inflammatory drugs
– the presence of local infections in the region to be treated